21-34834451-T-C
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 1P and 5B. BS1PS4_SupportingBP4
This summary comes from the ClinGen Evidence Repository: NM_001754.5(RUNX1):c.764A>G (p.His255Arg) is a missense variant with a MAF of 0.0003937 (0.03937%, 2/5080, 2 alleles) in the East Asian subpopulation of the gnomAD v3.1.2 cohort, which is between 0.00015 (0.015%) and 0.0015 (0.15%) (BS1). This missense variant has a REVEL score < 0.50 (0.483) and a SpliceAI score ≤ 0.20 (0.01) (BP4). This variant has been reported in one proband meeting at least one of the RUNX1-phenotypic criteria (PS4_supporting; PMID:31034769). In summary, this variant meets criteria to be classified as likely benign. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BS1, BP4, PS4_supporting. LINK:https://erepo.genome.network/evrepo/ui/classification/CA10014361/MONDO:0011071/008
Frequency
Consequence
NM_001754.5 missense
Scores
Clinical Significance
Conservation
Publications
- hereditary thrombocytopenia and hematologic cancer predisposition syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
- acute myeloid leukemiaInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000133 AC: 2AN: 150140Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000120 AC: 3AN: 249528 AF XY: 0.0000148 show subpopulations
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1457548Hom.: 0 Cov.: 32 AF XY: 0.00000276 AC XY: 2AN XY: 724094 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000133 AC: 2AN: 150140Hom.: 0 Cov.: 31 AF XY: 0.0000273 AC XY: 2AN XY: 73130 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 Uncertain:2
This sequence change replaces histidine, which is basic and polar, with arginine, which is basic and polar, at codon 255 of the RUNX1 protein (p.His255Arg). This variant is present in population databases (rs746977462, gnomAD 0.02%). This missense change has been observed in individual(s) with thrombocytopenia and/or leukemia (PMID: 31034769). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 567760). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on RUNX1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
Acute myeloid leukemia;C1832388:Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 Uncertain:1
- -
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome Benign:1
NM_001754.5(RUNX1):c.764A>G (p.His255Arg) is a missense variant with a MAF of 0.0003937 (0.03937%, 2/5080, 2 alleles) in the East Asian subpopulation of the gnomAD v3.1.2 cohort, which is between 0.00015 (0.015%) and 0.0015 (0.15%) (BS1). This missense variant has a REVEL score < 0.50 (0.483) and a SpliceAI score ≤ 0.20 (0.01) (BP4). This variant has been reported in one proband meeting at least one of the RUNX1-phenotypic criteria (PS4_supporting; PMID: 31034769). In summary, this variant meets criteria to be classified as likely benign. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BS1, BP4, PS4_supporting. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at